Methadone Maintenance Treatment: Is It Possible to Adapt the Daily Doses to the Metabolic Activity of the Patient?
Effective Fluconazole Therapy for Liver Transplant Recipients During Continuous Hemodiafiltration
Prediction of Metabolic Activity From Genotype: The Gene–Dose Effect of N-Acetyltransferase
Relation Between Dosage of Carbamazepine and Concentration in Hair and Plasma Samples From a Compliant Inpatient Epileptic Population
Determination of Sildenafil Citrate in Plasma by High-Performance Liquid Chromatography and a Case for the Potential Interaction of Grapefruit Juice With Sildenafil Citrate
Bioanalysis of Racemic Reboxetine and Its Desethylated Metabolite in a Therapeutic Drug Monitoring Setting Using Solid Phase Extraction and HPLC
Mycophenolic Acid Plasma Concentrations: Influence of Comedication
Analytical Validation for a Series of Marker Compounds Used to Assess Renal Drug Elimination Processes
Urine Drug Screens in Overdose Patients Do Not Contribute to Immediate Clinical Management
Fully Automated On-Line Determination of Olanzapine in Serum for Routine Therapeutic Drug Monitoring
Sensitive and Rapid Method for the Simultaneous Quantification of the HIV-Protease Inhibitors Indinavir, Nelfinavir, Ritonavir, and Saquinavir in Human Plasma by Reversed-Phase Liquid Chromatography
Screening for Detection of New Antidepressants, Neuroleptics, Hypnotics, and Their Metabolites in Urine by GC-MS Developed Using Rat Liver Microsomes
Effect of Coadministered Drugs and Ethanol on the Binding of Therapeutic Drugs to Human Serum In Vitro
Phenytoin Intoxication Induced by Fluvoxamine
7th International Congress of LATDMCT in Washington DC September 1–6, 2001 • Mayflower Hotel, Washington Program Overview
Abstract Specifications